神経変性疾患の特徴
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。この研究は神経変性疾患 (NDD) の8つの主要な特徴を概説し,そのメカニズムを理解するための総合的な枠組みを提供します. このアプローチは,効果的なNDD治療のために患者の層分化とパーソナライズされた治療法を改善することを目的としています.
科学分野
- 神経科学
- 遺伝学
- 生物化学
背景
- 神経変性疾患 (NDD) は複雑な遺伝的および生化学的経路を伴う.
- 現存する研究により,NDDに寄与する多くの要因が特定されています.
研究 の 目的
- NDDの8つの主要な特徴を統合する枠組みを提示する.
- NDDの病原性,分類,治療を理解するための基礎を確立する.
主な方法
- NDDに関する既存の研究の文献レビューと合成.
- 8つの主要な特徴とそのバイオマーカーの特定と説明
主要な成果
- NDDの8つの特徴は,タンパク質の集積,シナプス機能障害,プロテオスタシスの不均衡,細胞骨格の問題,エネルギー代謝の欠陥,DNA/RNAの損傷,炎症,細胞死です.
- これらの特徴の間の相互作用は説明されています.
- 各特徴のバイオマーカーについて説明します.
結論
- 8つの特徴に基づいた総合的な枠組みは NDD 研究を進めることができます.
- この枠組みは,病原性メカニズムを定義し,NDDを分類することをサポートします.
- NDDに対するパーソナライズされた多標的治療の設計を容易にする.
関連する概念動画
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
The cephalic phase is a conditioned or learned response to familiar foods. Our appetite or desire for a particular food modifies the preparatory responses directed by the brain. Individuals may produce more saliva and stomach...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....